Wellington Partners
Sanofi et al. back €47m series-B for MinervaX
MinervaX has so far raised a total of $81.5m in funding, including grants
Wellington, HBM lead €22m round for Adrenomed
Round follows the company's €24m series-D in November 2019, also backed by Wellington and HBM
Longitude Capital leads $40m round for Polares Medical
Existing investors Decheng, Endeavour Vision, IDO, Earlybird and Wellington also take part
Wellington Partners makes seed investment in Sirs Therapeutics
Life science and technology investor Wellington is the majority owner of the early-stage company
Immatics acquired by sponsor-backed Arya
Immatics will receive proceeds of approximately $252m upon closing of the deal
Partech leads €30m series-B for Amboss
Existing investors Cherry Ventures, Wellington Partners and Holtzbrinck Digital also take part
VC firms back €20m series-A for Stipe
Novo Holdings co-leads the round with Arix and Wellington Partners, and Sunstone Ventures invest
BtoV, Wellington and Seroba co-lead $48m series-C for Quanta
Existing investors BtoV, Wellington and Seroba all invested in the company's series-A in 2009
BioGeneration, Wellington lead €30m series-A for Confo
Fund+ and Perceptive Advisors, Capricorn, Qbic, PMV, Mints, V-Bio Ventures and VIB joined the round
VCs in $50m round for Onfido
Deal for the automated background check provider was led by the venture arms of SBI and Salesforce
LSP in $50m series-A for Snipr Biome
Lundbeckfonden Emerge invested an undisclosed sum in an exploratory investment in 2017
VC firms in $25m round for Polares Medical
Earlybird Venture Capital, Wellington Partners and Endeavour Vision also take part
Wellington Partners et al. in €22m series-B for Tricares
Investors back France-based Tricares, a specialist in tricuspid regurgitation treatment
VC firms take part in €10m series-C for Themis
Proceeds of the financing will be used to continue developing emerging virus vaccines
VC firms sell Invendo Medical to Ambu for €225m
Selling shareholders include Xeraya, TVM, Wellington, 360 Capital and Heidelberg Innovation
VC firms back $58m series-E for Immatics
Dievini Hopp Biotech holding, Wellington Partners, AT Impf and Amgen all invest in the round
Crane leads $30m series-C for Onfido
Existing VC backers also took part in the round for the automated background check platform
Balderton leads $7m series-A for Dalia
Backers include existing investors Wellington Partners and IBB-Bet
Wellington Partners leads €14m financing round for UroMems
Round includes €2m of funding from BPI France's PIA programme, adding to a €12m series-A
MPM in iOmx Therapeutics' €40m series-A
Proceeds will be used to develop proprietary product candidates
Wellington, Seed Capital lead DKK 13m Tonsser series-A
International business angels also took part in the funding round
Endeavour et al. lead $25m series-D for Endostim
Endeavour Vision led the funding round alongside Gimv and Wellington Partners
Gimv et al. lead €36m series-A for G-Therapeutics
Listed buyout house Gimv invested €6m in the funding round led by LSP and Inkef
Idinvest et al. in $25m series-B for Onfido
Automated background checking firm is to expand in the US after its rival's recent $40m round